Your wounds won't wait.
Find a Physician now
of Medicare contractors and commercial medical insurance policies cover Apligraf treatment for VLUs and DFUs*
*Data on file. Organogenesis Inc. The coverage information provided shall not be construed as a statement, promise, or guarantee that coverage will be received. Insurance coverage varies and is subject to change at any time. Work with your provider to determine your level of coverage.
Apligraf® is a unique product for treating Diabetic Foot Ulcers (DFUs) and Venous Leg Ulcers (VLUs).
Apligraf is FDA-approved for the treatment of venous leg ulcers and diabetic foot ulcers lasting longer than one month that have not adequately responded to conventional therapy. It contains living cells, proteins produced by the cells, and collagen. Complications may include suspected wound or non-wound infection, skin inflammation, wound drainage, swelling, a skin tear or cut, pain, a new ulcer, red, flaky skin, bone infection, rash, low or high blood sugar, bruising, swelling, worsening ulcer, and dry skin. Apligraf should not be used if your wound is infected or if you are allergic to cow collagen or the agarose shipping medium. For more information, please read the complete prescribing information available at Apligraf.com.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.